ClinicalTrials.Veeva

Menu

Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study

S

Shamir Medical Center (Assaf-Harofeh)

Status

Completed

Conditions

Knee Osteoarthritis

Treatments

Dietary Supplement: Methylsulfonylmethane (MSM)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
  • radiographic confirmed knee OA according to the Kellgren & Lawrence scale

Exclusion criteria

  • acute septic arthritis
  • inflammatory arthritis
  • any other type of arthritis
  • history of knee buckling or recent knee injury
  • lack of physical or mental bility to perform or comply with the treatment procedure
  • diabetes mellitus
  • fibromyalgia or other chronic pain syndromes
  • concurrent anti-coagulant/anti-platelet drugs
  • arthroscopy or intra-articular injections in the previous 3 months

Trial design

0 participants in 1 patient group

Purified MSM
Experimental group
Treatment:
Dietary Supplement: Methylsulfonylmethane (MSM)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems